Cargando…

Cancer patients receiving immune checkpoint inhibitor therapy are at an increased risk for atherosclerotic cardiovascular disease

The widespread clinical use of immune checkpoint inhibitors (ICI) has increased our knowledge on their adverse effects on chronic inflammatory diseases. Atherosclerosis, a low-grade lipid-driven inflammatory disease of the larger arteries, is commonly present in cancer patients. A major concern is t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lutgens, Esther, Seijkens, Tom T.P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Hypothesis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7057415/ https://www.ncbi.nlm.nih.gov/pubmed/32034065 http://dx.doi.org/10.1136/jitc-2019-000300

Ejemplares similares

Statins and immune checkpoint inhibitors: a strategy to improve the efficacy of immunotherapy for cancer?
por: Vos, Winnie G, et al.
Publicado: (2022)

Immune checkpoint inhibitor treatment and atherosclerotic cardiovascular disease: an emerging clinical problem
por: Poels, Kikkie, et al.
Publicado: (2021)

E3 Ubiquitin Ligases as Immunotherapeutic Target in Atherosclerotic Cardiovascular Disease
por: Poels, Kikkie, et al.
Publicado: (2020)

Hypothesis: does adrenalitis caused by immune checkpoint-inhibitors put melanoma patients at an elevated risk for recurrence?
por: Harsch, Igor Alexander
Publicado: (2019)

The CD40-CD40L Dyad as Immunotherapeutic Target in Cardiovascular Disease
por: Bosmans, Laura A., et al.
Publicado: (2020)

Immune Checkpoint Inhibitor Therapy Aggravates T Cell–Driven Plaque Inflammation in Atherosclerosis
por: Poels, Kikkie, et al.
Publicado: (2020)

Impact of tumor mutational burden on checkpoint inhibitor drug eligibility and outcomes across racial groups
por: Hsiehchen, David, et al.
Publicado: (2021)

Serum albumin: a pharmacokinetic marker for optimizing treatment outcome of immune checkpoint blockade
por: Zheng, Ming
Publicado: (2022)

Development of tumor lysis syndrome (TLS): A potential risk factor in cancer patients receiving anticancer therapy
por: Rasool, Mahmood, et al.
Publicado: (2014)

Hypothetical Pathway for Formation of Cholesterol Microcrystals Initiating the Atherosclerotic Process
por: Subczynski, Witold K., et al.
Publicado: (2020)

Assessing the risk of cardiovascular events in patients receiving immune checkpoint inhibitors
por: Torrente, María, et al.
Publicado: (2022)

Implications of prognostic variables in the assessment of autoimmunity in hepatitis C patients receiving interferon therapy
por: Arooj, Mahwish, et al.
Publicado: (2016)

A New Risk Factor for Cardiovascular Events in Patients Receiving Immune Checkpoint Inhibitor Therapy?
por: Thavendiranathan, Paaladinesh, et al.
Publicado: (2022)

Essential fatty acids and their metabolites could function as endogenous HMG-CoA reductase and ACE enzyme inhibitors, anti-arrhythmic, anti-hypertensive, anti-atherosclerotic, anti-inflammatory, cytoprotective, and cardioprotective molecules
por: Das, Undurti N
Publicado: (2008)

Evolutionary analysis of WD40 super family proteins involved in spindle checkpoint and RNA export: Molecular evolution of spindle checkpoint
por: Reddy, Duvvuru muni Rajasekhara, et al.
Publicado: (2008)

Metformin promotes cholesterol efflux in macrophages by up-regulating FGF21 expression: a novel anti-atherosclerotic mechanism
por: Luo, Fei, et al.
Publicado: (2016)

The G2 checkpoint—a node‐based molecular switch
por: de Gooijer, Mark C., et al.
Publicado: (2017)

Immuno-PET Imaging of Atherosclerotic Plaques with [(89)Zr]Zr-Anti-CD40 mAb—Proof of Concept
por: Poels, Kikkie, et al.
Publicado: (2022)

Important genetic checkpoints for insulin resistance in salt-sensitive (S) Dahl rats
por: Shehata, Marlene F
Publicado: (2008)

Sympatholytic Mechanisms for the Beneficial Cardiovascular Effects of SGLT2 Inhibitors: A Research Hypothesis for Dapagliflozin’s Effects in the Adrenal Gland
por: Lymperopoulos, Anastasios, et al.
Publicado: (2021)

Modulation of vitamin D signaling is a potential therapeutic target to lower cardiovascular risk in chronic kidney disease
por: Hu, Peng, et al.
Publicado: (2011)

Comparative modeling of CCRL1, a key protein in masked immune diseases and virtual screening for finding inhibitor of this protein
por: Behjati, Mohaddeseh, et al.
Publicado: (2012)

How to detour Treg cells in T cell-based antitumor immune therapy
por: Zheng, Shu, et al.
Publicado: (2013)

Cardiovascular Disease and Psychiatric Comorbidity: The Potential Role of Perseverative Cognition
por: Larsen, Britta A., et al.
Publicado: (2009)

Immune Checkpoint Inhibitors and Atherosclerotic Vascular Events in Cancer Patients
por: Inno, Alessandro, et al.
Publicado: (2021)

Thrombocytopenia in patients with melanoma receiving immune checkpoint inhibitor therapy
por: Shiuan, Eileen, et al.
Publicado: (2017)

Increased abscopal responses after radiation therapy for oligoprogressive patients receiving immune checkpoint inhibitors?
por: Doyen, Jérôme, et al.
Publicado: (2023)

Possible Role of Platelet GluR1 Receptors in Comorbid Depression and Cardiovascular Disease
por: Chen, Hu
Publicado: (2009)

Current surgical instrument labeling techniques may increase the risk of unintentionally retained foreign objects: a hypothesis
por: Ipaktchi, Kyros, et al.
Publicado: (2013)

Antibody-Mediated Inhibition of CTLA4 Aggravates Atherosclerotic Plaque Inflammation and Progression in Hyperlipidemic Mice
por: Poels, Kikkie, et al.
Publicado: (2020)

A Hypothesis: Supplementation with Mushroom-Derived Active Compound Modulates Immunity and Increases Survival in Response to Influenza Virus (H1N1) Infection
por: Chunchao, Han, et al.
Publicado: (2011)

Immune checkpoint inhibitors and the risk of major atherosclerotic cardiovascular events in patients with high-risk or advanced melanoma: a retrospective cohort study
por: Wang, Charlie, et al.
Publicado: (2022)

Screening of inhibitors for S130G inhibitor resistant mutants of TEM type beta-lactamase
por: Baig, Mohd Hassan, et al.
Publicado: (2012)

Establishing Imaging Biomarkers of Host Immune System Efficacy during Glioblastoma Therapy Response: Challenges, Obstacles and Future Perspectives
por: Candiota, Ana Paula, et al.
Publicado: (2022)

Immune oncology, immune responsiveness and the theory of everything
por: Turan, Tolga, et al.
Publicado: (2018)

Matrix Metalloproteinase-9 (MMP9)—A Mediating Enzyme in Cardiovascular Disease, Cancer, and Neuropsychiatric Disorders
por: Rybakowski, Janusz K.
Publicado: (2009)

MicroRNA-132 may play a role in coexistence of depression and cardiovascular disease: A hypothesis
por: Zheng, Zhihua, et al.
Publicado: (2013)

Absence of a Hernia Sack in Patients Undergoing Prenatal Repair of Spina Bifida Increases the Risk of Developing Shunt-Dependent Hydrocephalus
por: Pastuszka, Agnieszka, et al.
Publicado: (2023)

Screening and analysis of acetyl-cholinesterase (AChE) inhibitors in the context of Alzheimer's disease
por: Khan, Mohd. Babu, et al.
Publicado: (2018)

Serotonin 5-HT(2A) Receptor Function as a Contributing Factor to Both Neuropsychiatric and Cardiovascular Diseases
por: Nichols, Charles D.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_ula4a6fvu0qt70bemobinksioj